Adrian St. Clair Brown
17Patents
5h-index
15Co-inventors
63Inventor score
Filing activity: Jul 22, 1994 → Nov 25, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6077532A | Pharmaceutical ion exchange resin composition | Human Necessities | 78 | Expired |
| US8877776B2 | (L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | Chemistry; Metallurgy | 47 | Active |
| US9809549B2 | Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer | Chemistry; Metallurgy | 24 | Active |
| US5508044A | Diltiazem pharmaceutical spheroid formulation | Human Necessities | 11 | Expired |
| US5525355A | Laxative compositions | Human Necessities | 7 | Expired |
| US7842308B2 | Pharmaceutical formulation | Human Necessities | 5 | Expired |
| US11098015B2 | Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer | Chemistry; Metallurgy | 5 | Active |
| US11091439B2 | Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer | Chemistry; Metallurgy | 4 | Active |
| US11091440B2 | Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)- N′-(4-fluorophenyl)cyclopropane-1,1 -dicarboxamide, and crystalline forms thereof for the treatment of cancer | Chemistry; Metallurgy | 4 | Active |
| US8361498B2 | Pharmaceutical formulation | Human Necessities | 3 | Active |
| US8147871B2 | Pharmaceutical formulations | Human Necessities | 3 | Active |
| US7883721B2 | Pharmaceutical formulation | Human Necessities | 2 | Expired |
| US10590102B2 | Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]methanone | Chemistry; Metallurgy | 1 | Active |
| US8673350B2 | Pharmaceutical formulations | Human Necessities | 0 | Active |
| US11254649B2 | Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone | Chemistry; Metallurgy | 0 | Active |
| US12275706B2 | Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US8367101B2 | Pharmaceutical formulation | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.